Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
NIH On R29 Phase-Out; Grant Review Appeals Process Changed
This article is from
The Cancer Letter
archive.
Vol. 24 No. 03 | January 23, 1998
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
FDA Guidance for Public Comment at Advisory Committee Meetings
December 10, 2010
TCL Archive
Duke Picks Lyerly To Direct Cancer Center
May 2, 2003
TCL Archive
McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.
June 2, 2000
TCL Archive
Gene Patterns Predict Lymphoma Response To Treatment
June 28, 2002
TCL Archive
ImClone Protocol Generates More Questions Than Answers.
February 15, 2002
TCL Archive
FDA Committee Approves NDA for Mitxantrone
March 21, 1986